At-home dialysis pioneer Outset Medical Inc. has been coming off a successful year, posting $102.6m in full-year 2021 revenues, an increase of 105% year-over-year, and tripling its install base for at-home dialysis Tablo.
The publicly traded company exited 2021 with more than double the backlog of Tablo orders from year-end 2020, which Trigg told investors during a fourth quarter and full-year earnings call on 16 February, provides the company with “significant visibility and confidence” for its 2022 revenues
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?